CARLOS DIAZ: Open Payments
NPI 1881160687 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 35 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $267 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $344 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $293 |
| Corium, LLC | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Neuronetics, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Azstarys, SPRAVATO, REXULTI, NEUROSTAR TMS THERAPY SYSTEM, Qelbree.
Industry payments across AL — which companies pay providers there.
